Simona Iacobelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison	BONE MARROW TRANSPLANTATION	2024
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia	IMMUNOTHERAPY	2024
Pollen variability in Quercus L. species and relative systematic implications	PLANT PHYSIOLOGY AND BIOCHEMISTRY	2023
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling	HAEMATOLOGICA	2023
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT	BONE MARROW TRANSPLANTATION	2023
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia	THE NEW ENGLAND JOURNAL OF MEDICINE	2022
Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT	BONE MARROW TRANSPLANTATION	2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP	BONE MARROW TRANSPLANTATION	2022
Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT	BONE MARROW TRANSPLANTATION	2022
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study	JOURNAL OF CLINICAL MEDICINE	2022
Analyzing differences between restricted mean survival time curves using pseudo-values	BMC MEDICAL RESEARCH METHODOLOGY	2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101	SCIENCE ADVANCES	2022
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation	LEUKEMIA	2021
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT	BRITISH JOURNAL OF HAEMATOLOGY	2021
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2021
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT	EUROPEAN JOURNAL OF HAEMATOLOGY	2021
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14). A study from the CMWP-EBMT	BONE MARROW TRANSPLANTATION	2021
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP	EUROPEAN JOURNAL OF HAEMATOLOGY	2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT	BRITISH JOURNAL OF HAEMATOLOGY	2020
Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: risk factors and association with mortality	JOURNAL OF INFECTION	2020